Acceleron Pharma Inc (XLRN.O)

XLRN.O on Consolidated Issue listed on NASDAQ Global Market

24 Apr 2015
Change (% chg)

$-0.95 (-2.77%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for XLRN.O


Acceleron Pharma Inc. is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of protein therapeutics for cancer and rare diseases. The Company’s research focuses on the biology of the Transforming Growth Factor-Beta (TGF-b) protein superfamily, a large and diverse group of... (more)


Beta: --
Market Cap(Mil.): $1,091.61
Shares Outstanding(Mil.): 32.79
Dividend: --
Yield (%): --


  XLRN.O Industry Sector
P/E (TTM): -- 160.23 41.71
EPS (TTM): -1.50 -- --
ROI: -37.47 -0.86 16.20
ROE: -47.88 -2.81 17.00
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: ValuEngine, Inc.
Provider: ValuEngine, Inc.
Provider: Pechala's Reports
Provider: Reuters Investment Profile

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks